Literature DB >> 2119920

Autoantibodies to crude human leucocyte interferon (IFN), native human IFN, recombinant human IFN-alpha 2b and human IFN-gamma in healthy blood donors.

C Ross1, M B Hansen, T Schyberg, K Berg.   

Abstract

Recently, naturally occurring antibodies to IFN-alpha were discovered in a few systemic lupus erythematosus (SLE) and cancer patients; however, in most patients monitored for anti-IFN antibodies before treatment, no antibodies were found. In an attempt to explain the 'IFN-blocking effect' that we observed in all serum samples we investigated 200 sera from healthy blood donors. We isolated the globulin fraction, and used rabbit anti-human IgG and IgM columns, protein A columns and T-gel affinity chromatography to isolate human IgG and IgM. All sample fractions were tested in a biological IFN neutralization assay by means of a sensitive MTT-assay. We found that normal human serum contained autoantibodies to crude human leucocyte IFN, native human fibroblast IFN, recombinant human leucocyte IFN-alpha 2b and recombinant human IFN-gamma, and that these naturally occurring antibodies were biologically active immunoglobulins of IgG and IgM type. These anti-IFN antibodies were also present in purified human normal immunoglobulin pools. We conclude that all humans have naturally occurring anti-interferon antibodies in their serum, and it is a tempting theory that human cytokines and lymphokines are, at least partly, regulated by immunoglobulins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2119920      PMCID: PMC1535177          DOI: 10.1111/j.1365-2249.1990.tb05403.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodies.

Authors:  R G Steis; J W Smith; W J Urba; J W Clark; L M Itri; L M Evans; C Schoenberger; D L Longo
Journal:  N Engl J Med       Date:  1988-06-02       Impact factor: 91.245

2.  Salt-promoted adsorption: recent developments.

Authors:  J Porath
Journal:  J Chromatogr       Date:  1986-04-11

3.  Thiophilic adsorption of immunoglobulins--analysis of conditions optimal for selective immobilization and purification.

Authors:  T W Hutchens; J Porath
Journal:  Anal Biochem       Date:  1986-11-15       Impact factor: 3.365

Review 4.  Immunoblotting and dot immunobinding--current status and outlook.

Authors:  H Towbin; J Gordon
Journal:  J Immunol Methods       Date:  1984-09-04       Impact factor: 2.303

5.  Patient with circulating antibodies to alpha-interferon.

Authors:  K E Mogensen; P Daubas; I Gresser; D Sereni; B Varet
Journal:  Lancet       Date:  1981-11-28       Impact factor: 79.321

Review 6.  Human leukocyte interferon: production, purification, stability, and animal experiments.

Authors:  K Cantell; S Hirvonen; K E Mogensen; L Pyhälä
Journal:  In Vitro Monogr       Date:  1974

7.  Antibodies to human leucocyte interferons in cancer patients.

Authors:  P W Trown; M J Kramer; R A Dennin; E V Connell; A V Palleroni; J Quesada; J U Gutterman
Journal:  Lancet       Date:  1983-01-15       Impact factor: 79.321

8.  Thiophilic adsorption--a new method for protein fractionation.

Authors:  J Porath; F Maisano; M Belew
Journal:  FEBS Lett       Date:  1985-06-17       Impact factor: 4.124

9.  Autoantibodies against human beta interferon following treatment with interferon.

Authors:  A Vallbracht; J Treuner; K H Manncke; D Niethammer
Journal:  J Interferon Res       Date:  1982

10.  Naturally occurring anti-interferon antibodies in Lou/c rats.

Authors:  J De Maeyer-Guignard; A Cachard-Thomas; E De Maeyer
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

View more
  14 in total

1.  Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations.

Authors:  M Wadhwa; A Meager; P Dilger; C Bird; C Dolman; R G Das; R Thorpe
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Toward a new generation of vaccines: the anti-cytokine therapeutic vaccines.

Authors:  D Zagury; A Burny; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 3.  Mechanisms of action of interferon-beta in multiple sclerosis.

Authors:  B G Arnason; A Dayal; Z X Qu; M A Jensen; K Genç; A T Reder
Journal:  Springer Semin Immunopathol       Date:  1996

Review 4.  Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity.

Authors:  P Imbach; J Akatsuka; V Blanchette; A Burek-Kozlowska; J Bussel; G Gaedicke; A Gianella-Borradori; E Gugler; A Hirt; B Imholz
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

5.  Detection of autoantibodies to cytokines.

Authors:  K Bendtzen; M B Hansen; C Ross; M Svenson
Journal:  Mol Biotechnol       Date:  2000-03       Impact factor: 2.695

6.  Serum-induced suppression of interferon (IFN) activity. Lack of evidence for the presence of specific autoantibodies to IFN-alpha in normal human sera.

Authors:  M B Hansen; M Svenson; K Bendtzen
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

7.  Binding of cytokines to pharmaceutically prepared human immunoglobulin.

Authors:  M Svenson; M B Hansen; K Bendtzen
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

8.  High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.

Authors:  C Ross; M Svenson; M B Hansen; G L Vejlsgaard; K Bendtzen
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

9.  Neutralizing interferon beta antibodies in melanoma patients treated with recombinant and natural interferon beta.

Authors:  G Fierlbeck; T Schreiner; B Schaber; A Walser; G Rassner
Journal:  Cancer Immunol Immunother       Date:  1994-10       Impact factor: 6.968

10.  Natural human antibodies to gamma interferon interfere with the immunomodulating activity of the lymphokine.

Authors:  A Turano; A Balsari; E Viani; S Landolfo; L Zanoni; F Gargiulo; A Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.